EHC
Encompass Health Corp
NYSE: EHC · HEALTHCARE · MEDICAL CARE FACILITIES
$104.82
+4.18% today
Updated 2026-06-05
Market cap
$10.07B
P/E ratio
17.38
P/S ratio
1.66x
EPS (TTM)
$5.84
Dividend yield
0.72%
52W range
$93 – $128
Volume
0.9M
WallStSmart proprietary scores
75
out of 100
Grade: B+
Buy
Investment rating
8.0
Growth
A6.0
Quality
B7.5
Profitability
B+6.7
Valuation
B6/9
Piotroski F-Score
Moderate
2.1
Altman Z-Score
Grey zone
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$140.50
+34.04%
12-Month target
$97.72
-6.77%
Intrinsic (DCF)
$72.27
Margin of safety
-56.95%
1 Strong Buy12 Buy0 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ ROE 24.16% — strong efficiency
+ Free cash flow $150.70M — positive
Risks
- 56.95% above intrinsic value
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $4.35B | $4.80B | $5.37B | $5.94B | $6.07B |
| Net income | $271.00M | $352.00M | $455.70M | $566.20M | $194.50M |
| EPS | — | — | — | — | $5.84 |
| Free cash flow | $121.70M | $267.70M | $360.30M | $439.20M | $150.70M |
| Profit margin | 6.23% | 7.33% | 8.48% | 9.54% | 10.00% |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-05-15 | COLTHARP, DOUGLAS E | Sale | 27,694 | — |
| 2026-05-15 | COLTHARP, DOUGLAS E | Buy | 27,694 | $32.94 |
| 2026-05-15 | COLTHARP, DOUGLAS E | Sale | 27,693 | $106.83 |
Peer comparison
Smart narrative
Encompass Health Corp trades at $104.82. representing a P/E of 17.38x trailing earnings. Our Smart Value Score of 75/100 indicates the stock is good. The company scores 6/9 on the Piotroski F-Score. With an Altman Z-Score of 2.12, it sits in the grey zone. TTM revenue stands at $6.07B. with profit margins at 10.00%. Our DCF model estimates intrinsic value at $72.27.
Frequently asked questions
What is Encompass Health Corp's stock price?
Encompass Health Corp (EHC) trades at $104.82, on a P/E of 17.4x and a P/S of 1.7x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is Encompass Health Corp overvalued?
Encompass Health Corp carries a Smart Value Score of 75/100 (Grade B+), which we rate Buy. That score blends growth, quality, and valuation into one read. On valuation specifically, our conservative DCF puts intrinsic value at $72.27 against the $104.82 price, so on cash flow terms the market is paying a premium for Encompass Health Corp's growth. The Buy rating reflects that growth and quality, while the DCF flags that the price already assumes a lot.
What is the price target of Encompass Health Corp (EHC)?
The 12-month analyst consensus target is $140.50, about 34.0% above the current $104.82. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is the intrinsic value of Encompass Health Corp (EHC)?
Our DCF model estimates intrinsic value at $72.27, a -57.0% margin of safety versus today's $104.82. Intrinsic value is what the projected cash flows are worth today. A negative reading means the price is running ahead of that conservative estimate, leaving little downside cushion if growth slows.
What is Encompass Health Corp's revenue?
Encompass Health Corp's trailing twelve-month revenue is $6.07B. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
Encompass Health Corp's Altman Z-Score is 2.12, which places it in the grey zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryMEDICAL CARE FACILITIES
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio1.66x
ROE24.16%
Beta0.60
50D MA$104.49
200D MA$109.98
Shares out0.10B
Float0.10B
Short ratio—
Avg volume0.9M
Performance
1 week+2.00%
1 month+6.85%
3 months+4.37%
YTD+1.05%
1 year—
3 years—
5 years—